Newer antidepressants in irritable bowel syndrome: What is the evidence?

Archives of Medical Science

Volumn 4, Issue 1, 2008, Pages 77-78

  Talley, Nicholas J ^a,b  

^a MAYO CLINIC   (United States)

^b Division of Gastroenterology and Hepatology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; PLACEBO; SEROTONIN UPTAKE INHIBITOR;

ABDOMINAL PAIN; BLOATING; CLINICAL TRIAL; CONSTIPATION; DEFECATION DISORDER; DRUG EFFICACY; EVIDENCE BASED MEDICINE; HUMAN; IRRITABLE COLON; LIBIDO DISORDER; NOTE; PERISTALSIS; SEROTONIN SYNDROME; SIDE EFFECT; SLEEP DISORDER; SUICIDAL IDEATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; UPPER GASTROINTESTINAL BLEEDING; WEIGHT REDUCTION;

EID: 42549159550     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (12)

1. Talley NJ. Irritable bowel syndrome. Intern Med J 2006; 36: 724-8.
2. Cremonini F, Talley NJ. Treatments targeting putative mechanisms in irritable bowel syndrome. Nat Clin Pract Gastroenterol Hepatol 2005; 2: 82-8.
3. Talley NJ, Spiller R. Irritable bowel syndrome: a little understood organic bowel disease? Lancet 2002; 360: 555-64.
4. Gorad DA, Libby GY, Farthing M. Influence of antidepressants on whole gut and orocaecal transit times in health and irritable bowel syndrome. Aliment Pharmacol Ther 1994; 8: 159-66.
5. Panzer MJ. Are SSRIs really more effective for anxious depression? Ann Clin Psychiatry 2005; 17: 23-9.
6. Rahimi R, Nikfar S, Abdollahi M. Selective serotonin reuptake inhibitors for the management of irritable bowel syndrome: a meta-analysis of randomized controlled trials. Arch Med Sci 2008; 4: 71-6.
7. Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med 2008; 5: e45.
8. Moayyedi P. Meta-analysis: can we mix apples and oranges? Am J Gastroenterol 2004; 99: 2297-301.
9. Stahl SM, Grady MM, Moret C, Briley M. SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants. CNS Spectr 2005; 10: 732-47.
10. Tack J, Fried M, Houghton LA, Spicak J, Fisher G. Systematic review: the efficacy of treatments for irritable bowel syndrome - a European perspective. Aliment Pharmacol Ther 2006; 24: 183-205.
11. Drossman DA, Toner BB, Whitehead WE, et al. Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders. Gastroenterology 2003; 125: 19-31.
12. Hansen RA, Gartlehner G, Lohr KN, Gaynes BN, Carey TS. Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder. Ann Intern Med 2005; 143: 415-26.